Brief: Qualigen Therapeutics Reports Q3 Financial Results And Provides Corporate Update
15/11/2022 12:42
Nov 15 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS, INC. REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* QUALIGEN THERAPEUTICS INC - SHAREHOLDERS APPROVED REVERSE
STOCK
SPLIT TO SATISFY NASDAQ CONTINUED LISTING QUALIFICATIONS
* QUALIGEN THERAPEUTICS INC - BELIEVES ITS CASH IS
SUFFICIENT TO
FUND ITS ANTICIPATED OPERATIONS INTO Q3 OF 2023
* QUALIGEN THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.10
Source text for Eikon: ID:nGNX5QD3gG
Further company coverage: QLGN.O
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise